The Department of Health (DoH) will convene this week an independent panel that will review the results of the clinical trials of Dengvaxia, Health Secretary Francisco Duque said on Tuesday.

Duque said the team will review the results of the five-year observation period found in clinical trials as well as data from the post-marketing surveillance of the Food and Drug Administration and the post-immunization report of the department’s Epidemiology bureau.